PASITHEA THERAPEUTICS CORP. Earnings Per Share (Basic)
PASITHEA THERAPEUTICS CORP. (KTTA) reported Earnings Per Share (Basic) of -$0.16 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- PASITHEA THERAPEUTICS CORP. earnings per share, basic for the quarter ending 2026-06-30 was -$0.16.
- PASITHEA THERAPEUTICS CORP. earnings per share, basic for the quarter ending 2026-03-31 was -$0.12.
- PASITHEA THERAPEUTICS CORP. earnings per share, basic for the quarter ending 2025-12-31 was -$0.79.
- PASITHEA THERAPEUTICS CORP. earnings per share, basic for the quarter ending 2025-09-30 was -$0.41.
- PASITHEA THERAPEUTICS CORP. earnings per share, basic for fiscal 2025 was -$2.91.
- PASITHEA THERAPEUTICS CORP. earnings per share, basic for fiscal 2024 was -$12.69.
- PASITHEA THERAPEUTICS CORP. earnings per share, basic for fiscal 2023 was -$0.42.
- PASITHEA THERAPEUTICS CORP. earnings per share, basic for fiscal 2022 was -$1.76.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 8 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.16 10-Q · filed 2026-08-14 | -$0.29 10-Q · filed 2026-08-14 | -$0.79 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.11 derived: net income ÷ weighted average shares · filed 2026-08-14 | |||||
| 2026-03-31 | -$0.12 10-Q · filed 2026-05-15 | -$0.70 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.08 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.57 derived: net income ÷ weighted average shares · filed 2026-08-14 | |||||
| 2025-12-31 | -$0.79 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$1.30 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$1.96 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$2.91 10-K · filed 2026-03-30 | |||||
| 2025-09-30 | -$0.41 10-Q · filed 2025-11-13 | -$1.03 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$2.02 10-Q · filed 2025-11-13 | -$3.26 derived: net income ÷ weighted average shares · filed 2026-08-14 | |||||
| 2025-06-30 | -$0.66 10-Q · filed 2026-08-14 | -$1.85 10-Q · filed 2026-08-14 | -$3.44 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$5.30 derived: net income ÷ weighted average shares · filed 2026-08-14 | |||||
| 2025-03-31 | -$1.61 10-Q · filed 2026-05-15 | -$3.89 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$6.48 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$9.80 derived: net income ÷ weighted average shares · filed 2026-08-14 | |||||
| 2024-12-31 | -$2.53 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$5.38 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$9.02 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$12.69 10-K · filed 2026-03-30 | |||||
| 2024-09-30 | -$2.87 10-Q · filed 2025-11-13 | -$6.58 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$10.28 10-Q · filed 2025-11-13 | -$15.14 derived: net income ÷ weighted average shares · filed 2025-11-13 | |||||
| 2024-06-30 | -$3.71 10-Q · filed 2025-08-14 | -$7.41 10-Q · filed 2025-08-14 | -$12.27 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$14.96 derived: net income ÷ weighted average shares · filed 2025-11-13 | |||||
| 2024-03-31 | -$3.70 10-Q · filed 2025-05-15 | -$8.56 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$11.25 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$14.02 derived: net income ÷ weighted average shares · filed 2025-11-13 | |||||
| 2023-12-31 | -$4.86 derived: net income ÷ weighted average shares · filed 2025-03-24 | -$7.54 derived: net income ÷ weighted average shares · filed 2025-03-24 | -$10.34 derived: net income ÷ weighted average shares · filed 2025-03-24 | -$0.42 10-K · filed 2025-03-24 | |||||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 | -$5.75 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$0.02 10-Q · filed 2023-11-13 | $1.00 derived: net income ÷ weighted average shares · filed 2024-11-13 | |||||
| 2023-06-30 | -$0.01 10-Q · filed 2023-08-11 | -$0.02 10-Q · filed 2023-08-11 | $0.57 derived: net income ÷ weighted average shares · filed 2024-11-13 | $1.74 derived: net income ÷ weighted average shares · filed 2024-11-13 | |||||
| 2023-03-31 | -$0.01 10-Q · filed 2023-05-12 | $0.26 derived: net income ÷ weighted average shares · filed 2024-11-13 | $0.98 derived: net income ÷ weighted average shares · filed 2024-11-13 | $3.76 derived: net income ÷ weighted average shares · filed 2024-11-13 | |||||
| 2022-12-31 | $0.08 derived: net income ÷ weighted average shares · filed 2024-03-29 | $0.47 derived: net income ÷ weighted average shares · filed 2024-03-29 | $2.04 derived: net income ÷ weighted average shares · filed 2024-03-29 | -$1.76 10-K · filed 2024-03-29 | -$0.55 10-K · filed 2023-03-30 | ||||
| 2022-09-30 | -$0.01 10-Q · filed 2023-11-13 | -$0.17 10-Q · filed 2022-11-14 | -$0.29 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$0.05 10-Q · filed 2023-11-13 | -$0.36 10-Q · filed 2022-11-14 | -$0.37 derived: net income ÷ weighted average shares · filed 2023-11-13 | |||
| 2022-06-30 | -$0.02 10-Q · filed 2023-08-11 | -$0.11 10-Q · filed 2022-08-15 | -$0.03 10-Q · filed 2023-08-11 | -$0.18 10-Q · filed 2022-08-15 | -$0.17 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$0.29 derived: net income ÷ weighted average shares · filed 2023-11-13 | |||
| 2022-03-31 | -$0.01 10-Q · filed 2023-05-12 | -$0.07 10-Q · filed 2022-05-16 | -$0.05 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$0.15 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$0.23 derived: net income ÷ weighted average shares · filed 2023-11-13 | ||||
| 2021-12-31 | $0.04 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.07 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.15 derived: net income ÷ weighted average shares · filed 2023-03-30 | -$0.21 10-K · filed 2023-03-30 | |||||
| 2021-09-30 | -$0.17 10-Q · filed 2022-11-14 | -$0.26 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.33 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | -$0.09 10-Q · filed 2022-08-15 | -$0.16 10-Q · filed 2022-08-15 | |||||||
| 2021-03-31 | -$0.07 10-Q · filed 2022-05-16 | ||||||||
| 2020-12-31 | $0.00 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |